Australia markets closed

Verrica Pharmaceuticals Inc. (VRCA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.26+0.50 (+7.40%)
At close: 04:00PM EDT
7.26 0.00 (0.00%)
After hours: 04:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,124
5,124
9,032
12,000
0
Cost of revenue
746
746
725
0
-
Gross profit
4,378
4,378
8,307
12,000
-
Operating expenses
Research development
20,295
20,295
12,198
15,929
15,673
Selling general and administrative
47,305
47,305
17,405
26,979
24,508
Total operating expenses
67,600
67,600
29,603
42,908
40,181
Operating income or loss
-63,222
-63,222
-21,296
-30,908
-40,181
Interest expense
3,962
3,962
2,172
4,295
3,034
Total other income/expenses net
-2,551
-2,551
-1,495
-
-1
Income before tax
-66,995
-66,995
-24,487
-35,080
-42,694
Income from continuing operations
-66,995
-66,995
-24,487
-35,080
-42,694
Net income
-66,995
-66,995
-24,487
-35,080
-42,694
Net income available to common shareholders
-66,995
-66,995
-24,487
-35,080
-42,694
Basic EPS
-1.08
-
-0.72
-1.30
-1.71
Diluted EPS
-1.08
-
-0.72
-1.30
-1.71
Basic average shares
44,054
-
34,163
27,044
24,996
Diluted average shares
44,054
-
34,163
27,044
24,996